Universal Health (UHS) Q2 Earnings Beat on Acute Care Strength

Share Repurchase Update Adjusted EBITDA, net of NCI, is now estimated to be in the range of $2.154-$2.226 billion. The midpoint of the guidance suggests a 25.7% improvement from the 2023 figure. UHS increased its adjusted EPS guidance in the range of $15.4-$16.2. The midpoint of the forecast indicates a rise of 49.9% from the 2023 figure. Other Medical Sector Releases HCA Healthcare reported second-quarter 2024 adjusted EPS of $5.50, which beat the Zacks Consensus Estimate by 10.7%. The bottom line improved ...